Fact CheckerSign in

NCT05008432Completed

Sleep Apnea in Heart Failure With Preserved Ejection Fraction

Sleep Apnea in Heart Failure With Preserved Ejection Fraction - Exercise Capacity and Impact of Positive Airway Pressure Therapy

Source: ClinicalTrials.gov · Last updated 28 Aug 2024

Brief summary (registry, in English)

This is a prospective interventional study to better understand i) the prevalence of Obstructive Sleep Apnea (OSA) in Heart Failure with preserved Ejection Fraction (HFpEF), ii) its hemodynamic correlates, and iii) the impact of intervention with Continuous Positive Airway Pressure (CPAP) on quality of life.

Status (registry)
Completed
Study type
Observational
Enrollment
48 (actual)
First submitted
15 Jul 2021
Start date
7 Oct 2021
Primary completion date
24 Jul 2024
Lead sponsor
Mayo Clinic
NCT number
NCT05008432

What you commit to

  • Study type: Observational
  • Participants enrolled: 48
  • From 7 Oct 2021 to the primary completion date, 24 Jul 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Complex congenital heart disease
  • Other valve disease requiring surgical intervention
  • Terminal illness (other than HF) with expected survival of less than 1 year

Lab values

  • Ejection fraction \<40%

Other

  • Obstructive hypertrophic cardiomyopathy
  • Constrictive pericarditis or tamponade
  • Active myocarditis
  • Inability to comply with planned study procedures
  • Pregnancy or breastfeeding mothers

Who the study is looking for

  • Age ≥ 18 years
  • Diagnosis of HFpEF by catheterization with resting PCWP\>15 mmHg or exercise PCWP\>25 mmHg or hospitalization with HFpEF
  • Ambulatory (not wheelchair/scooter dependent)
  • If no known diagnosis of OSA, must not be pacemaker dependent with either atrial pacing or VVI without sinus rhythm
  • If no known diagnosis of OSA, must be able to temporarily hold nitrates or alpha channel blockers for home WatchPAT testing (3 hour washout period)

Age in the registry: 18 years to 99 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Mayo Clinic - Rochester
Coordinator of this site? Confirm its status
RochesterUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.